Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study — Evangelos Briasoulis (2007) | RDL Network
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study
Vasilios Karavasilis, P. Kosmidis, Konstantinos N. Syrigos, Polyxeni Mavropoulou, Meletios A Dimopoulos, Vassiliki Kotoula, Dimitrios Pectasides, Ioannis Boukovinas, G. Klouvas, Anna Kalogera‐Fountzila, Christos N. Papandreou, George Fountzilas, Evangelos Briasoulis
Meletios A Dimopoulos, C. Bakoyannis, Vassilis Georgoulias, Christos Papadimitriou, Lia A. Moulopoulos, C. Deliveliotis, A. Karayannis, Ioannis Varkarakis, Gerasimos Aravantinos, Anastasios Zervas, D Pantazopoulos, George Fountzilas, Aristotelis Bamias, Zacharias Kyriakakis, Αchilles Anagnostopoulos, Αθανάσιος Γιαννόπουλος, P. Kosmidis
Evangelos Briasoulis, Epaminontas Samantas, Haralabos P. Kalofonos, D. Skarlos, Constantina Christodoulou, George Fountzilas, A. Barnias, Meletios A Dimopoulos, P. Kosmidis, Nicholas Pavlidis
G. Stathopoulos, S. Rigatos, Meletios A Dimopoulos, T. Giannakakis, G. Foutzilas, Charalambos Kouroussis, Dimitrios Janninis, Gerasimos Aravantinos, N. Androulakis, Sofia Agelaki, J. Stathopoulos, Vassilis Georgoulias
Discussion(0)
No comments yet. Be the first to comment.